PRIMARY CUTANEOUS T-CELL LYMPHOMA
Clinical trials for PRIMARY CUTANEOUS T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CUTANEOUS T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY CUTANEOUS T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vitamin a derivative takes on tough lymphoma
Disease control Recruiting nowThis early-stage trial is testing a new form of fenretinide (a vitamin A-like drug) given by IV for people with T-cell non-Hodgkin lymphoma that has come back or stopped responding to treatment. The study has two parts: first, finding the safest dose in small groups of patients, …
Matched conditions: PRIMARY CUTANEOUS T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Massive T-Cell lymphoma database aims to unlock new insights
Knowledge-focused Recruiting nowThis study is creating a large database of information and tissue samples from 1,000 people with T-cell lymphoma. Researchers will use this data to learn more about the disease and how to improve patient outcomes. Participants provide medical information and optional blood and na…
Matched conditions: PRIMARY CUTANEOUS T-CELL LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC